# CHRNB2

## Overview
The CHRNB2 gene encodes the cholinergic receptor nicotinic beta 2 subunit, a critical component of the neuronal nicotinic acetylcholine receptors (nAChRs), which are categorized as ligand-gated ion channels. These receptors are integral to synaptic transmission within the central nervous system, playing a pivotal role in modulating neurotransmitter release and influencing cognitive processes (Liu2011The; Ehringer2007Association). The CHRNB2 gene is located on chromosome 1 and is composed of six exons that encode a protein with 502 amino acids, featuring multiple transmembrane domains essential for its function (Lueders1999Genomic; Rempel1998The). The beta 2 subunit is predominantly expressed in the brain, where it forms heteromeric receptors with alpha subunits, notably the α4β2 configuration, which is the most prevalent in the brain and is involved in cholinergic signaling (Lueders2002Genetic; Phillips2001CHRNB2). Mutations in CHRNB2 have been linked to neurological disorders such as autosomal dominant nocturnal frontal lobe epilepsy, highlighting its clinical significance (Schaaf2014Nicotinic; Steinlein2008Neuronal).

## Structure
The CHRNB2 gene encodes the beta 2 subunit of the nicotinic acetylcholine receptor, which is a ligand-gated ion channel. The primary structure of the CHRNB2 protein consists of 502 amino acids, with the coding sequences distributed across six exons interrupted by five introns (Rempel1998The). The secondary structure includes three hydrophobic transmembrane domains located in exon 5, while exon 6 contains the fourth transmembrane domain (Rempel1998The). The signal peptide is 25 amino acids long, with 21 amino acids encoded by exon 1 and 4 by exon 2 (Lueders1999Genomic).

The tertiary structure involves the 3D folding of the protein, which includes a large extracellular domain, a large cytoplasmic domain, and a short extracellular C-terminal domain (Lueders1999Genomic). The quaternary structure of the nicotinic acetylcholine receptor involves the assembly of various combinations of α and β subunits to form a functional receptor (Lueders1999Genomic).

Post-translational modifications such as phosphorylation and glycosylation are common, which can affect the protein's function and localization. The CHRNB2 gene may also produce different splice variant isoforms, potentially influencing its role in the nervous system. However, specific details on these isoforms are not provided in the context.

## Function
The CHRNB2 gene encodes the beta-2 subunit of the neuronal nicotinic acetylcholine receptors (nAChRs), which are pentameric ligand-gated ion channels involved in synaptic transmission in the central nervous system. These receptors are primarily located on presynaptic nerve terminals and play a crucial role in modulating neurotransmitter release, such as dopamine and gamma-aminobutyric acid (GABA), influencing cognitive processes and contributing to neuronal communication (Liu2011The; Ehringer2007Association).

The most abundant form of heteromeric nAChR in the brain contains α4 and β2 subunits, which are involved in the transmission of cholinergic signals. These receptors are activated by the neurotransmitter acetylcholine, allowing the flow of ions across the cell membrane, leading to neuronal excitation (Lueders2002Genetic; Phillips2001CHRNB2). The β2-nAChRs are abundantly expressed in various brain regions, including the cortex, cerebellum, and the ventral tegmental area, which is part of the mesolimbic dopamine reward pathway (Lueders2002Genetic).

In healthy human cells, the CHRNB2 gene's function is crucial for maintaining proper ion flow and receptor sensitivity to neurotransmitters, which is essential for normal neuronal communication and cognitive functions (Phillips2001CHRNB2).

## Clinical Significance
Mutations in the CHRNB2 gene, which encodes the beta-2 subunit of the nicotinic acetylcholine receptor, are associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). This condition is characterized by clusters of motor seizures occurring during sleep, often involving stereotyped movements such as limb stiffening and dystonic posturing (Schaaf2014Nicotinic; Steinlein2008Neuronal). Specific mutations, such as V287M and I312M, have been identified in affected families and are known to increase the receptor's sensitivity to acetylcholine, contributing to the epileptic phenotype (Phillips2001CHRNB2; Bertrand2005The). These mutations are typically located in the transmembrane regions of the receptor, affecting its ion channel function (Steinlein2007Genetic).

In addition to epilepsy, mutations in CHRNB2 can lead to cognitive impairments, particularly in verbal memory tasks, as observed in individuals carrying the I312M mutation (Cho2008Autosomal; Bertrand2005The). The clinical presentation of ADNFLE can vary significantly, with some individuals experiencing mild symptoms that do not require medical intervention, while others have more severe manifestations (Phillips2001CHRNB2). These findings underscore the role of CHRNB2 mutations in neurological disorders and highlight the gene's clinical significance.


## References


[1. (Lueders1999Genomic) Kira K. Lueders, Rosemary W. Elliott, Ingo Marenholz, Dietmar Mischke, Michael DuPree, and Dean Hamer. Genomic organization and mapping of the human and mouse neuronal β2-nicotinic acetylcholine receptor genes. Mammalian Genome, 10(9):900–905, September 1999. URL: http://dx.doi.org/10.1007/s003359901111, doi:10.1007/s003359901111. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s003359901111)

[2. (Rempel1998The) Nicole Rempel, Sibilla Heyers, Hartmut Engels, E. Sleegers, and O. K. Steinlein. The structures of the human neuronal nicotinic acetylcholine receptor β2- and α3-subunit genes ( chrnb2 and chrna3 ). Human Genetics, 103(6):645–653, December 1998. URL: http://dx.doi.org/10.1007/s004390050885, doi:10.1007/s004390050885. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390050885)

[3. (Bertrand2005The) Daniel Bertrand, Frances Elmslie, Elaine Hughes, John Trounce, Thomas Sander, Sonia Bertrand, and Ortrud K. Steinlein. The chrnb2 mutation i312m is associated with epilepsy and distinct memory deficits. Neurobiology of Disease, 20(3):799–804, December 2005. URL: http://dx.doi.org/10.1016/j.nbd.2005.05.013, doi:10.1016/j.nbd.2005.05.013. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.nbd.2005.05.013)

[4. (Lueders2002Genetic) Kira K. Lueders, Stella Hu, Louise McHugh, Max V. Myakishev, Leo A. Sirota, and Dean H. Hamer. Genetic and functional analysis of single nucleotide polymorphisms in the β2-neuronal nicotinic acetylcholine receptor gene (chrnb2). Nicotine &amp; Tobacco Research, 4(1):115–125, February 2002. URL: http://dx.doi.org/10.1080/14622200110098419, doi:10.1080/14622200110098419. This article has 48 citations.](https://doi.org/10.1080/14622200110098419)

[5. (Liu2011The) Hui Liu, Cailing Lu, Zhenzhong Li, Shiyi Zhou, Xiaoqiao Li, Liri Ji, Qiang Lu, Ruijuan Lv, Liwen Wu, and Xu Ma. The identification of a novel mutation of nicotinic acetylcholine receptor gene chrnb2 in a chinese patient: its possible implication in non-familial nocturnal frontal lobe epilepsy. Epilepsy Research, 95(1–2):94–99, June 2011. URL: http://dx.doi.org/10.1016/j.eplepsyres.2011.03.002, doi:10.1016/j.eplepsyres.2011.03.002. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.eplepsyres.2011.03.002)

[6. (Cho2008Autosomal) Yong-Won Cho, Sang-Doe Yi, Jeong-Geun Lim, Dae-Kwang Kim, and Gholam K. Motamedi. Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with chrnb2 mutation i312m in the neuronal nicotinic acetylcholine receptor. Epilepsy &amp; Behavior, 13(2):361–365, August 2008. URL: http://dx.doi.org/10.1016/j.yebeh.2008.04.017, doi:10.1016/j.yebeh.2008.04.017. This article has 21 citations.](https://doi.org/10.1016/j.yebeh.2008.04.017)

[7. (Schaaf2014Nicotinic) Christian P. Schaaf. Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 16(9):649–656, September 2014. URL: http://dx.doi.org/10.1038/gim.2014.9, doi:10.1038/gim.2014.9. This article has 78 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2014.9)

[8. (Steinlein2008Neuronal) O.K. Steinlein and D. Bertrand. Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases. Biochemical Pharmacology, 76(10):1175–1183, November 2008. URL: http://dx.doi.org/10.1016/j.bcp.2008.07.012, doi:10.1016/j.bcp.2008.07.012. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bcp.2008.07.012)

[9. (Ehringer2007Association) Marissa A. Ehringer, Hilary V. Clegg, Allan C. Collins, Robin P. Corley, Thomas Crowley, John K. Hewitt, Christian J. Hopfer, Kenneth Krauter, Jeffrey Lessem, Soo Hyun Rhee, Isabel Schlaepfer, Andrew Smolen, Michael C. Stallings, Susan E. Young, and Joanna S. Zeiger. Association of the neuronal nicotinic receptor β2 subunit gene (chrnb2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(5):596–604, January 2007. URL: http://dx.doi.org/10.1002/ajmg.b.30464, doi:10.1002/ajmg.b.30464. This article has 95 citations.](https://doi.org/10.1002/ajmg.b.30464)

[10. (Steinlein2007Genetic) Ortrud K. Steinlein. Genetic disorders caused by mutated acetylcholine receptors. Life Sciences, 80(24–25):2186–2190, May 2007. URL: http://dx.doi.org/10.1016/j.lfs.2007.03.007, doi:10.1016/j.lfs.2007.03.007. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.lfs.2007.03.007)

[11. (Phillips2001CHRNB2) Hilary A. Phillips, Isabelle Favre, Martin Kirkpatrick, Sameer M. Zuberi, David Goudie, Sarah E. Heron, Ingrid E. Scheffer, Grant R. Sutherland, Samuel F. Berkovic, Daniel Bertrand, and John C. Mulley. Chrnb2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy*. The American Journal of Human Genetics, 68(1):225–231, January 2001. URL: http://dx.doi.org/10.1086/316946, doi:10.1086/316946. This article has 257 citations.](https://doi.org/10.1086/316946)